Ads
related to: melanoma metastasis
Search results
Researchers discover new therapeutic target for the treatment ofmelanoma resistant to targeted...
Medical Xpress· 1 day agoAn international research team led by scientists from the University of Liège has discovered an...
... Survival & Distant Metastasis-Free Survival Versus... Stage III/IV Melanoma Following Complete...
Digital Journal· 5 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant
Katie Couric Encourages Eye Health Checkups After Friend Is Diagnosed with Rare Cancer
People via Yahoo News· 2 days agoThe 67-year-old revealed that her friend was diagnosed with uveal melanoma, a rare eye cancer Jim...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via AOL· 5 days agoThe study is evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy...
...PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other...
Lake Arrowhead Mountain News· 7 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 4 days agoThe data showed a sustained improvement in recurrence-free survival (RFS) and distant metastasis...
Philogen and Sun Pharma seek EMA approval for melanoma therapy
Pharmaceutical Technology via Yahoo Finance· 4 days agoIntended to be administered intralesionally for four weeks, Nidlegy aims to enhance the immune...
Intralesional Therapy for Melanoma Effective, May Have Systemic Activity
MedPage Today· 7 days agoPreoperative antibody fusion daromun significantly reduced relapse versus upfront surgery
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoAfter a median of 34.9 months, the regimen reduced the risk of cancer recurrence by 49% and the risk...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
Ad
related to: melanoma metastasis